Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model

Antiglycolytic agents inhibit cell metabolism and modify the tumor’s microenvironment, affecting chemotherapy resistance mechanisms. In this work, we studied the effect of the glycolytic inhibitors 3-bromopyruvate (3BP), dichloroacetate (DCA) and 2-deoxyglucose (2DG) on cancer cell properties and on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Andrea, Rocha, Ana Catarina, Barbosa, Flávia, Baião, Ana, Silva, Patrícia, Sarmento, Bruno, Queirós, Odília
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611291/
https://www.ncbi.nlm.nih.gov/pubmed/36297455
http://dx.doi.org/10.3390/pharmaceutics14102021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611291/
https://www.ncbi.nlm.nih.gov/pubmed/36297455
http://dx.doi.org/10.3390/pharmaceutics14102021

Ejemplares similares